✦ LIBER ✦

P125 - Influence of disease duration on adalimumab efficacy in Crohn's disease: subanalysis of the CARE trial

✍ Scribed by W. Reinisch; R. Lofberg; E. Louis; M. Kron; A. Camez; A. Robinson; P.F. Pollack

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T1215 Subanalysis of Remission Rates By

✍ Reinisch, Walter; Lofberg, Robert; Louis, Edouard; Kron, Martina; Camez, Anne; R 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Efficacy of adalimumab by disease durati

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P118 - Adalimumab's effect on extraintes

✍ E. Louis; R. Lofberg; W. Reinisch; M. Kron; A. Camez; A. Robinson; P.F. Pollack 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 60 KB

P011 GLOBAL SAFETY OF ADALIMUMAB IN CROH

✍ J.F. Colombel; R. Panaccione; W.J. Sandborn; P. Rutgeerts; S.B. Hanauer; W. Rein 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 70 KB

Efficacy and safety of adalimumab in Cro

✍ Mei Lan HUANG; Zhi Hua RAN; Jun SHEN; Xiao Bo LI; Xi Tao XU; Shu Dong XIAO 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 445 KB

P117 - Global safety of adalimumab in tr

✍ J.F. Colombel; R. Panaccione; W.J. Sandborn; P. Rutgeerts; S.B. Hanauer; W. Rein 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 51 KB